Resources

Accelerate your journey from discovery to first-in-human with a smarter, CMC-led approach to lead optimisation and selection.

How 3Biotech helped a Belgian biotech move from candidate selection to a complete IMPD dossier in just 18 months through end-to-end CMC management.

Explore how 3Biotech guided a rare-disease biologic from pilot scale to industrial manufacturing, securing FDA Breakthrough and EMA PRIME designations.

Define your therapy’s value and direction with a robust Target Product Profile. This free whitepaper and template help biotech leaders align scientific, regulatory, and commercial strategies from the outset.

See how 3Biotech enabled a Swiss oncology company to scale complex ADC production globally, maintaining GMP compliance and quality across continents.

A practical template to help early-stage biotech teams identify, evaluate, and mitigate scientific, regulatory, clinical, and commercial risks.

A strategic guide for biotech teams developing small molecules or biologics. Learn how to align CMC, regulatory, and clinical workstreams to shorten timelines and reduce risk — includes free Gantt chart templates.

Discover how 3Biotech transformed an autologous CAR-T programme from research-grade foundations into a clinical-ready CMC pathway with clear risks, timelines and governance.